Search
for
Sort by
Research 91–120 of 349
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- National scientific medical meeting 1996 abstracts
- Adverse Cutaneous Reactions to Antidepressants
- Dermatologists’ Role in Interdisciplinary Care for Obsessive-Compulsive Disorder and Body-Focused Repetitive Behaviors
- Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen
- Cancer prevalence after exposure to Wnt-activating drugs: a systematic review
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Eosinophilia associated with clozapine – A case report
- Trichotillomania – therapeutic possibilities
- Hair Loss Associated with Sertraline: Two Case Reports and Review
- Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Cannabis sativa
- 10-Year-Old Female with an Irregularly Shaped Patch of Hair Loss
- Unconventional side effects of antidepressants: Focus on emotional blunting
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid
- Under-diagnosed Psychiatric Syndrome I: Trichotillomania
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Trichotillomania
- 02 Management of difficult infections in SLE
- Novel drugs of United States Food and Drug Administration approved in 2024
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Approach to the patient with hair loss
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome